Swiss National Bank boosted its position in shares of Healthequity Inc (NASDAQ:HQY) by 2.0% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 97,000 shares of the company’s stock after buying an additional 1,900 shares during the period. Swiss National Bank owned 0.16% of Healthequity worth $9,158,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Advisors Asset Management Inc. increased its holdings in shares of Healthequity by 5,212.2% in the second quarter. Advisors Asset Management Inc. now owns 72,086 shares of the company’s stock valued at $160,000 after purchasing an additional 70,729 shares during the period. Meeder Asset Management Inc. acquired a new position in shares of Healthequity in the third quarter valued at approximately $172,000. Rockefeller Capital Management L.P. acquired a new position in shares of Healthequity in the second quarter valued at approximately $179,000. Cerebellum GP LLC acquired a new position in shares of Healthequity in the third quarter valued at approximately $185,000. Finally, Sawtooth Solutions LLC acquired a new position in shares of Healthequity in the second quarter valued at approximately $207,000. 96.35% of the stock is currently owned by institutional investors.
Healthequity stock opened at $88.69 on Friday. Healthequity Inc has a 1-year low of $42.92 and a 1-year high of $101.58. The company has a market capitalization of $5.42 billion, a P/E ratio of 164.24, a price-to-earnings-growth ratio of 3.03 and a beta of 1.39.
A number of research analysts have recently issued reports on HQY shares. Zacks Investment Research raised Healthequity from a “sell” rating to a “hold” rating in a report on Tuesday, August 7th. KeyCorp boosted their target price on Healthequity from $90.00 to $105.00 and gave the company an “overweight” rating in a report on Tuesday, September 4th. Citigroup restated a “buy” rating and issued a $110.00 price target on shares of Healthequity in a research note on Wednesday, September 5th. Wells Fargo & Co lifted their price target on Healthequity from $84.00 to $105.00 and gave the company an “outperform” rating in a research note on Wednesday, September 5th. Finally, Cantor Fitzgerald lifted their price target on Healthequity from $68.00 to $80.00 and gave the company a “neutral” rating in a research note on Wednesday, September 5th. Four investment analysts have rated the stock with a hold rating, ten have issued a buy rating and one has issued a strong buy rating to the company’s stock. The company presently has an average rating of “Buy” and a consensus target price of $93.08.
In other Healthequity news, VP Darcy G. Mott sold 4,000 shares of the business’s stock in a transaction on Tuesday, November 20th. The stock was sold at an average price of $76.91, for a total transaction of $307,640.00. Following the sale, the vice president now directly owns 89,500 shares in the company, valued at $6,883,445. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Over the last quarter, insiders have sold 12,000 shares of company stock worth $1,027,400. 4.00% of the stock is owned by company insiders.
HealthEquity, Inc provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the United States. The company offers healthcare saving and spending platform, a cloud-based platform for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.
See Also: Capital Gains
Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Healthequity Inc (NASDAQ:HQY).
Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.